Formulation and Evaluation of Oxcarbazepine Suspension: In vitro/In vivo Correlation

Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 1

Abstract

Background: Information on economic burden of hypertension is needed for relevant decisions and policies due to escalating cost of disease management. Aims: The study assessed economic burden of pharmacotherapy in hypertension management on the National Health Insurance Scheme (NHIS) of Nigeria and the economies of antihypertensives selection. Study Design: Cross-sectional study. Place and Duration of Study: Out-patient-department of a private teaching hospital located in Lagos, Nigeria over four-month duration in 2011. Methodology: Two hundred and fifty case notes of hypertensive patients were randomly selected. These were assessed for costs of pharmacotherapeutic management of hypertension. Patients’ details such as demographic data, drug regimens and funding status were extracted from the case notes. Drugs’ prices were obtained from the hospital billing guide. Data presentation was by using descriptive statistics. Results: Two hundred and eight (83.2%) of the selected case notes met the study criteria. Diuretics were the most economical at an average monthly cost per prescription of NGN858.6 ($5.51) followed by the beta-blockers at NGN1,101.1 ($7.07) while fixed dose combinations were the costliest at NGN10,425.0 ($66.93). Health Maintenance Organizations (HMOs) having 104 (50.0%) of the cohort as enrollees incurred most of the cost at NGN446, 325.0 ($2,865.47) followed by NHIS 75 (36.0%) at NGN321, 354.0 ($2,063.14). An average monthly cost of antihypertensives per patient was highest for private patients NGN4, 314.47 ($27.69) and least for NHIS NGN4, 284.72 ($27.50). The national cost implication using the least average monthly antihypertensive cost per patient of NGN4,284 .72 ($27.50) for NHIS implies an average of NGN51,416.64 ($330.10) per annum for each patient and a whooping sum in excess of NGN1.054 trillion (over $6.76billion) for over 20 million affected hypertensive patients in Nigeria. Conclusion: Cost burden of hypertension management is high, incurred mostly by HMOs and NHIS. Diuretics were the most economical of all prescribed regimens.

Authors and Affiliations

A. Prameela Rani, V. Hema

Keywords

Related Articles

A New Approach for the Treatment of Diabetes and Nicotine Induced Cataract by Modulating Specific Ion-Channels Function in Rat Lens

Aim: Cataract is an eye disease characterized by a cloudiness of the normally transparent crystalline lens. Diabetes and smoking are the known risk factors for cataract development. It is well known fact that inorganic i...

Effect of Sub acute Exposure to Telfairia occidentalis Root, Pod and Stem Extracts on Some Liver and Renal Function Parameters in Rats

Aim: This study assessed the effect of twenty eight (28)-day exposure to aqueous extract of Telfairia occidentalis root, pod and stem on the liver and kidney of Wistar rats. Methodology: Sixty eight (68) wistar rats wer...

Phytomedicines of Sickle Cell Crisis in Mezam Division, Cameroon: Preventive and Curative Cares

Background: The aim of this study was to survey the Mezam Division of Cameroon, with a view to documenting how the population of that area treat sickle cells disease using medicinal plants, and to determine the need for...

Synthesis, Docking Study and Antifungal Activity Evaluation of Some 1,3-benzo[d]thiazole Analogs: A Promotion in Synthetic Method with Nano-γ-Al2O3/BF3-n under Solvent Free Conditions

Aim: Nano-γ-Al2O3/BF3-n was applied for the synthesis of 1,3-benzo[d]thiazole derivatives as a new solid acid catalyst. Benzothiazole is used as a pharmacological agent with a wide variety of biological activities such a...

Molecular Typing of Brucella melitensis Isolated from Patients and Animals by Pulsed Field Gel Electrophoresis from Iran

Background: The Brucellosis is recognized as a significant public health problem, with major economic and financial burdens in countries where the disease remains endemic. The disease is one of the most important worldwi...

Download PDF file
  • EP ID EP344664
  • DOI 10.9734/BJPR/2014/3983
  • Views 60
  • Downloads 0

How To Cite

A. Prameela Rani, V. Hema (2014). Formulation and Evaluation of Oxcarbazepine Suspension: In vitro/In vivo Correlation. Journal of Pharmaceutical Research International, 4(1), 70-78. https://europub.co.uk/articles/-A-344664